Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
| Study Name | |
| Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations | |
| ClinicalTrials.gov Identifier (if applicable) | |
| NCT04579380 | |
| Clinical Trial Category (check all that apply) | |
|
|
| Study Center | |
| Institution Name | |
| clinicaltrials.gov for full site list | |
| Country | |
| United States | |
| OVERVIEW – in layman’s terms (150 words max) | |
| This trial studies how well tucatinib works for solid tumors that make either more HER2 or a different type of HER2 than usual. The solid tumors studied in this trial have either spread to other parts of the body or cannot be removed completely with surgery. The trial will also look at what side effects happen |
|
| Enrollment | |
| ongoing | |
| Study Start Date | |
| 01/11/2021 | |
| Estimated Completion Date | |
| 5/31/2025 (active, not recruiting per recent update 4/24/23) | |